Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Current sp - milestone
10
Jan 04, 2008 05:46PM

Jan 04, 2008 05:51PM
2
Jan 05, 2008 08:33AM

Jan 05, 2008 09:14AM
2
Jan 05, 2008 09:29AM

Jan 05, 2008 09:37AM

Jan 05, 2008 10:03AM
3
Jan 05, 2008 10:21AM
1
Jan 07, 2008 08:46AM
4
Jan 07, 2008 10:19AM

We've had many postings, including mine, that have showed what revenue numbers are needed to achieve various EPS results.

Given approx 390 Million shares outstanding PTSC would need income of at least $390 million (if they had no expenses) to achieve a $1 annual EPS. That's about $100 million income per quarter. I don't think that will happen any time soon.

The problem is PTSC has yet to demonstrate it's EPS potential in actual 10Q results. We've all been looking at "potential" - for a very long time. It's time we see a couple of Qs of actuals that corrispond to the potential. That, I expect, will start in the April 10Q report. But the fog may not clear then either, because it's possible the recent settlement did not deliver a large one-time payment.


Jan 07, 2008 11:36AM
11
Jan 07, 2008 11:43AM
Share
New Message
Please login to post a reply